Table 2.
Factors associated with survival in ATTRwt (n = 101)
Variable | Univariate analysis Hazard Ratio (95% CI) | P | Multivariate analysis Hazard Ratio (95% CI) | P |
---|---|---|---|---|
TTR (mg/dL) | 0.93 (0.88 – 0.98) | 0.007 | 0.89 (0.84 – 0.95) | < 0.001 |
cTn-I (ng/mL) | 5.12 (2.43 – 10.81) | < 0.001 | 8.06 (3.01 – 21.57) | < 0.001 |
BNP (pg/mL) | 1.001 (1.001 – 1.002) | 0.002 | ||
LVEF (%) | 0.96 (0.94 – 0.99) | 0.001 | 0.97 (0.94 – 0.99) | 0.01 |
Creatinine (mg/dL) | 2.02 (1.14 – 3.60) | 0.02 | ||
Uric acid (mg/dL) | 1.14 (1.02 – 1.28) | 0.02 | ||
Sedimentation rate (mm/hr) | 1.03 (1.01 – 1.04) | 0.001 |
ATTRwt indicates wild-type transthyretin amyloidosis; TTR, transthyretin; cTn-I, cardiac troponin I; BNP, B-type natriuretic peptide; LVEF, left ventricular ejection fraction; and CI, confidence interval